• Molecular NameQuinethazone
  • SynonymChinetazone [dcit]; Chinethazonum; Quinetazona [inn-spanish]; Quinethazon; Quinethazonum [inn-latin]
  • Weight289.743
  • Drugbank_IDDB01325
  • ACS_NO73-49-4
  • Show 2D model
  • LogP (experiment)0.2
  • LogP (predicted, AB/LogP v2.0)1.05
  • pka9.3, 10.7
  • LogD (pH=7, predicted)1.04
  • Solubility (experiment)0.149 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.15
  • LogSw (predicted, AB/LogsW2.0)0.32
  • Sw (mg/ml) (predicted, ACD/Labs)0.2
  • No.of HBond Donors4
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA109.67
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A